FDA Inspection
Holy Cross of Silver Spring Blood BankHoly Cross of Silver Spring Blood Bank – FDA Inspection, Jul 22, 2010
Record Details
This FDA Inspection record concerns Holy Cross of Silver Spring Blood Bank, with an inspection on July 22, 2010, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Inspection Date
- July 22, 2010
- Product Type
- Biologics
View Company Profile
ID · fb49d866-28c9-4268-940f-cd4b46a45d6e
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 675251
- FDA center
- Biologics
- Project area
- Blood and Blood Products
FDA Citations
1- 21 CFR 606.100(b)Establish, maintain and follow manufacturing SOPs
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Holy Cross of Silver Spring Blood Bank
8| Date | Classification | Office | Project area |
|---|---|---|---|
| October 22, 2024 | Not classified | Baltimore District Office | |
| February 28, 2022 | NAI | Center for Biologics Evaluation and Research | Vaccines and Allergenic Products |
| January 29, 2019 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| May 25, 2017 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| January 13, 2015 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Holy Cross of Silver Spring Blood Bank
- FDA Inspection 1253461 - 2024-10-22
- FDA Inspection 1166014 - 2022-02-28
- FDA Inspection 1081239 - 2019-01-29
- FDA Inspection 1014489 - 2017-05-25
- FDA Inspection 910320 - 2015-01-13
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.